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1. Introduction
Neurons are one among the very few differentiated cell types which are strictly post-mitotic
and therefore non-renewable by sister cell divisions. The production of new neurons, or
neurogenesis, does though occur in limited areas of adult mammalian nervous system, due to
the existence of intrinsic stem cells which has been formally demonstrated by a primary culture
approach on adult brain tissues from mouse [1], man [2,3] and other species [4]. These “neural
stem cells” satisfy the general stemness criteria, i.e.: illimited proliferative activity, self-renewal
capacity, multipotency (i.e. capacity to generate all the differentiated cell types of their host
tissue, which for neural stem cells encompasses neurons, astrocytes, oligodendrocytes),
proliferative reactivity to tissue lesions and physiological signals [5]. This discovery has raised
great promise for clinical repair in neurology and led to coin a novel principle in cell therapy,
which consists in replacing lost neurons by grafting in vitro purified neural stem cells [6,7,8].
This theoretical principle has been challenged by the putative tumour-promoting potential of
grafted proliferative cells. Such risk can reasonably be ruled out by the recent demonstration
that adult brain-derived neural stem cells are highly resilient to tumorigenesis and senescence,
much more than embryonic neuroblasts, embryonic stem cells, induced pluripotent stem cells
or any other stem cell type from adult mammalian tissues [9]. However, the use of homotypic
neural stem cell transplantation in human clinics seems ethically difficult, since it requires
initial sampling of alive brain tissue. In order to overcome this limitation, we have developed
primary neural stem cell culture from adult porcine brain. The pig is indeed the non-primate
species that is immunologically closest to human [10], which already allowed successful
protocols of xenotransplantation in human clinics using in vitro-expanded primary cell
preparations from several adult pig tissues – but not from the nervous system.
© 2013 Liard and Moyse; licensee InTech. This is an open access article distributed under the terms of the
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2. General properties of neural stem cells in adult mammals
Neural stem cells are identified and isolated in primary cultures of adult nervous tissues in
the presence of epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF), by
the growth of cellular masses called “neurospheres” which include the three neural lineages:
neurons, astrocytes, oligodendrocytes [1]. This primary culture is termed “neurosphere assay”
(NSA) and allows to generate and expand great numbers of proliferative neurogenic cells
through successive passages [11]. Recent methodological refinements allowed to isolate and
distinguish neural stem cells per se from downstream progenitors, i.e. proliferative cells being
committed to a single lineage although yet undifferentiated [12].
Beside  the  two  initially  recognized  and  most  active  neurogenic  structures  of  adult
mammalian brain (the subventricular zone of telencephalon and the subgranular layer of
hippocampal  dentate  gyrus),  several  topographically  restricted  regions  of  the  central
nervous system were shown to yield neurospheres in EGF-bFGF-treated primary culture
and therefore to contain neural stem cells [13,14]. Spatial frequency among tissue and in
vivo  yield of neuronal versus glial progenies are highly variable, ranging among: 95% in
hippocampus and hypothalamus, 60-70% in SVZ-olfactory bulb system, 40% in dorsal vagal
complex, 0% in spinal cord despite as high a proliferation rate as in SVZ [15]. However,
in vitro-expanded neurospheres display strikingly reproducible properties, regarding both
growth dynamics (10-12 days for the primary generation, 6-7 days for the subsequent ones)
and lineage proportions after differentiation commitment by growth factor removal: 25%
neurons, 70% astrocytes, 5% oligodendrocytes [11].
Neural stem cells generate differentiated progenies, like other types of adult stem cells,
through several intermediate stages which can now be distinguished by their respective
marker combinations – or “molecular profiles” or “transcriptomic signatures” (Figure 1). The
biological properties of neural stem cells from adult nervous tissues are reminiscent of those
characterizing neural progenitors from embryos, especially in vitro. However, accumulated
data in the past decade have revealed important differences between these two categories of
neural precursor cells, which led to consider them as distinct cell types. The differences include
indeed intrinsic molecular mechanisms of proliferation and differentiation, as well as recep‐
tivity to extracellular signals [16,17,18]. Most interestingly, neural stem cells from adults are
much less teratogenic than embryonic stem cells and foetal neural progenitors [9,19, 20,21,22].
Primary cultures of neural stem cells from the archetypical subventricular zone of rodent,
which is the most highly proliferative of endogenous neurogenic niches in mammalian brain,
could indeed be maintained over more than 70 successive in vitro generations (or “passages”
in the neurosphere assay) without any alteration of growth kinetics, self-renewal capacity and
lineage potential [9]. In vivo ectopic grafts of in vitro-expanded neurospheres never triggered
tumors in experimental rodents [9], by contrast to primary cultures of other stem cell categories
from adult mammals [19,20,21]. In the recent years, some typical stem cells have been formally
characterized in a variety of mammalian tumors, including neural ones; however, these
“cancer stem cells” are distinct lineages from intrinsic stem cells of healthy tissues and seem
to arise de novo as a consequence of DNA damage independently of tissue stem cells [23]. In
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the case of neural tissues, it must be recalled that beyond early post-natal ages (4-years in man)
brain cancers are exclusively gliomas [24,25]. This fact renders most unlikely that adult neural
cancers might derive from neural stem cells. Indeed, in a recent extensive survey of above 2000
brain metastases from 500 patients, neural stem cells were never found affected [22]. Regarding
neurological repair aims for human clinics, the specially high resilience of adult neural stem
cells against tumorigenesis is a determinant advantage in view of cell therapy applications.
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Figure 1. The “neuropoietic system” of adult neurogenesis. Modelized from references 15,38.
3. Neurosphere isolation from adult pig brain subventricular zone
Neural progenitors have been isolated from foetal porcine brain by several laboratories in the
last years, by using the neurosphere assay. We decided to develop isolation of adult brain-
derived neural stem cells, because of their higher safety than other available proliferative
neurogenic cell types in terms of oncogenic potential (cf above). Neural stem cells are found
only in rare and discrete structures, the best characterized and most productive of which is the
subventricular zone (SVZ) of the forebrain in rodents. We have isolated and characterized for
the first time the neural stem cells of adult pig SVZ, by transposing the “neurosphere assay”
from routine protocols of rodent studies [26].
3.1. The key to success for the “neurosphere assay”: Adequate tissue sampling
This particular primary culture is known to be hampered by two pitfalls: i) delay between in
vivo blood supply arrest (upon either sacrifice of experimental animals or tissue explantation)
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and tissue immersion into appropriate fresh survival medium like the Hank’s one or artificial
cerebrospinal fluid (see below); ii) excess of non-competent tissue around the NSC-containing
area within the microdissected sample.
In order to minimize the duration of brain tissue sampling, which is lengthened in adult pig
by the requirement of dorsal skull sawing, we performed the surgical approach of telencephalic
subventricular region in deeply anesthetized pig instead of immediately after sacrifice. A
rough 10mm-thick, transverse section of midbrain was explanted and immediately transferred
into a large Petri dish filled with fresh Hank’s medium, and the subventricular zone was then
microdissected out of this thick slice on the basis of macroscopical neuroanatomical landmarks
by reference to a detailed pig brain atlas [27]. Despite this precaution, our first neurosphere
assay attempts on adult pig SVZ failed, which was subsequently attributed to improper tissue
sampling. Indeed, the telencephalic subventricular zone is proportionally much larger in adult
pig than in adult rodents, and proliferative activity is already known as highly heterogeneous
among the whole anatomical extent of SVZ in rodent brain [28]. We performed therefore the
subregional mapping of proliferative activity within adult pig SVZ, by Ki-67 immunohisto‐
chemistry using a routine protocol [29,30]. The Ki-67 protein is indeed a phylogenetically
conserved marker which is expressed exclusively during the cell division cycle of eukaryotic
cells, but throughout all its successive phases (G1-S-G2-M); it is therefore widely used in
clinical anatomo-pathology and oncology. Proliferative cells, appearing in situ as Ki-67
immunoreactive nuclei, were almost exclusively grouped in a narrow ventral subfield of the
Nissl-stained subventricular zone, lining the ventral border of lateral ventricle of adult pig
brain (Figure 2). The major lateral territory of adult pig SVZ was almost devoid of Ki-67
labelling (Figure 2). We have confirmed the anatomical restriction of the “niche” to such a small
subfield of neuroanatomically defined SVZ, by specific labelling of the radial glia which has
been extensively characterized in rodent brain SVZ, using double vimentin-glial fibrillary
acidic protein (GFAP) immunohistochemistry [26]. In vitro culture of neural stem cells from
adult pig brain became successful when the SVZ tissue explants were microdissected accord‐
ing to the anatomical lineaments of specific Ki-67 immunoreactive labelling.
3.2. Primary neurospheres from adult pig brain as a vehicle of neural stem cells
For primary cell culture (“neurosphere assay”), a piece of SVZ tissue was microdissected from
the pig forebrain slice in low-calcium artificial cerebrospinal fluid (aCSF: 124 mM NaCl, 5 mM
KCl, 3.2 mM MgCl2, 0.1 mM CaCl2, 26 mM NaHCO3, 100 mM glucose, pH 7.38, according to
Weiss et al., 1996). As previously described [30], the tissue sample was rinsed twice with aCSF,
and digested first in 40 U cystein-EDTA-βmercaptoethanol-preactivated papain (Sigma, L’Isle
D’Abeau, France) for 10 min at 37°C, then in 250 µL undiluted TrypLETM Express solution
(heat-resistant, microbially-produced, purified trypsin-like enzyme, Gibco cat 12604-013,
Invitrogen, Cergy-Pontoise, France) for 10 min at 37°C. After the addition of 750 µL of fresh
aCSF and centrifugation for 8 min at 400g at room temperature, the cell pellet was resuspended
in 1mL culture medium (Dulbecco’s modified Eagle medium [DMEM, Sigma], B27 supplement
[Gibco Invitrogen], 200 U/mL penicillin and 200 µg/mL streptomycin [Gibco Invitrogen])
containing 20ng/mL Epidermal Growth Factor (EGF, Gibco Invitrogen) and 20 ng/mL basic
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Figure 2. In situ localization of the proliferative cells of the adult pig SVZ (modified from original data of reference 26).
(A) Macroscopic aspect of Nissl-stained coronal section of adult pig forebrain. (B) Light microscopic aspect of the SVZ
region in a Nissl-stained pig brain section. (C) Ki-67 immunohistochemistry on adjacent section of the previous one,
with high magnification on the boxed area of B. Note the high density of Ki-67-positive nuclei in this area, as
reavealed by brown precipitate, which contrasts with the lateral field of SVZ devoid of Ki-67 immunoreactivity. Leg‐
end: cc: corpus callosum, Cx: cerebral cortex, lv: lateral telencephalic ventricle, S: septum pellucidum, St: striatum, SVZ:
subventricular zone.
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Fibroblast Growth Factor (bFGF, Gibco Invitrogen). The cells were dissociated gently with a
26G steel needle mounted on a disposable 1mL syringe, counted on a Malassez slide, and
seeded at various densities according to purported utilization. Optimal results were obtained
with either Corning 24-well plates or with Falcon 6-well ones. Seedings for basic cell biology
kinetics were performed at 3,000 cells per mL of culture medium (subclonal concentration).
Maximal neurosphere expansion for transplantation or molecular assays was obtained with
seeding at 30,000 cells per mL. Cultures must be monitored daily to follow the morphological
growth of the neurospheres; when their diameter reaches 150µm indeed, growth slows down
while sphere surface apparently thickens and hardens, and culture proves unable to be
expanded any more. Passage (i.e. sphere dissociation, cell resuspension and re-seeding as for
primary culture) was performed therefore when the majority of spheres was 100-120µm in
diameter.
For passage, the primary spheres were collected in sterile tubes, incubated for 45-60 min at
37°C in 250 µL undiluted TrypLETM Express solution (Gibco Invitrogen) per 6 mL culture-
derived pellet, and dissociated gently with a 26G steel syringe; dispersed cells were centri‐
fuged, resuspended in fresh proliferative medium, counted ant their dilution adjusted to be
seeded as above.
Both primary and passaged spheres were prone to two kinds of utilization:
• for neural stem cell expansion, subsequent passages were run in proliferative conditions,
i.e. in the presence of 20ng/mL EGF and 20ng/mL bFGF;
• for cell differentiation, spheres were picked with a Pasteur pipette, seeded in wells contain‐
ing poly-D-lysine (Sigma) precoated sterile coverslips and cultured in the above culture
medium (DMEM, B27, penicillin-streptomycin) in the absence of EGF and bFGF for 7-10
days.
All culture media were renewed by the replacement of 500 µL of medium per well every 2-3
days.
Stemness criteria fulfilment by adult pig SVZ-derived spheres in the presence of EGF and bFGF.
We have observed in our primary neurospheres from adult pig SVZ the properties which have
been established as the seminal criteria of neural stem cells since their pioneering discovery in
adult murine brain [1,11].
The existence of EGF/bFGF-dependent proliferative cells in the ventro-medial SVZ from adult pig
brain was demonstrated by the growth of spherical masses from dissociated pieces of this tissue
[26] which displayed similar morphology and size distribution to neurospheres obtained from
the rat SVZ [30]. Each pair of SVZ samples from 1 pig brain yielded routinely 1 million
dispersed cells for seeding, i.e. the total number of cells collected per pig SVZ was about 10
times that of mouse SVZ [11,31]. The pig SVZ spheres appeared though after a longer delay in
culture (9-12 days in vitro [DIV]) than primary neurospheres from adult rat SVZ (3-4 DIV: 30).
Each pair of SVZ from one pig generated 3000 primary spheres after 2 weeks in the present
culture conditions and at initial seeding densities of 30,000 cells per mL. These primary cells
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could be expanded linearly on this base through several passages (up to 6 with no change of
growth slope) [26].
The self-renewal capacity of primary sphere-generating cells from adult pig SVZ was established by
the obtention of novel spheres from dissociation of mature primary Spheres. Re-seeding of
dispersed neurosphere cells in the same proliferative medium after 12-14 DIV led to novel
“secondary” spheres that were morphologically similar to the primary spheres and grew
slightly faster than primary spheres. A second passage at 8-10 DIV led to tertiary spheres that
displayed similar morphology and growth rate to secondary spheres. In two independent
cultures from 2 pigs each, 5-6 subsequent passages could be performed with similar aspects
and cell number amplifications of respective generations. The second passage regularly
triggered a 3-time-magnification of total cell number, while other passage increments (I, III
and next ones) averaged 20-30% [26].
The multipotentiality and neural character of EGF/bFGF-dependent proliferative cells of adult pig
SVZ were demonstrated on mature spheres which were deprived of the 2 mitogens after having
reached proliferative maturity, by immunocytochemical detection of neuronal and neuroglial
markers in three distinct subpopulations of each sphere – according to the classical lineage test
of neurosphere assay [1,11,30]. Quantitative analysis with confocal microscopy indicated that
all neurospheres from adult pig SVZ yielded similar proportions of the three neural lineages:
25% neurons, 70% astrocytes, 5% oligodendrocytes. A discrete distribution of the three cell
lineages was also reproducibly observed inside the neurospheres, with oligodendrocytes being
buried in the core of the spheres while both astrocytes and neurons were concentrated at the
periphery [26].
3.3. Transcriptomic signature of neural stem cells in adult pig SVZ neurospheres
We have assayed the expression of phenotypic markers by RT-PCR on total RNA from
proliferative, undifferentiated SVZ neurospheres of adult pig SVZ, which were collected at the
second or third generation as described above. Pig SVZ neurospheres displayed positive
expression of RNAs encoding for:
• nestin, an intermediate filament which is systematically expressed by neural stem cells and
embryonic neural progenitors;
• the proliferation marker cyclin D1;
• the neural stem cell proteins Sox-2, Hes-1, p75NTR (the low-affinity receptor of neurotro‐
phins), Lhx2;
• the neuronal proteins βIII-tubulin, doublecortin (DCX), neuron-specific enolase (NSE),
Internexin α, Pbx1, Mash1, NeuroD1;
• the oligodendrocyte markers CNPase, Olig-2, PDGF-Rα (Figure 3).
The astrocyte marker glial fibrillary acidic protein (GFAP) has been detected on differentiated
neurospheres from adult pig SVZ by immunocytochemistry using the antibody against cow
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GFAP (cf above) but its transcript could not be detected in the proliferative neurosphere RNAs
(probably due to unknown specificity of porcine gene sequence and primers therefore).
The lack of Olig-1 transcripts is expected at this pro-differentiating stage since this gene is
expressed in the late phase of oligodendroglial lineage maturation [32,33]; it is also in keeping
with Hes-1 detection in the present proliferative spheres, since Hes-1 overexpression was
shown to correlate with Olig-1 down-regulation during differentiation [34,35].
In the persistent absence of any specific marker of either neural stem cell or neural committed
progenitors, this series of transcripts fits best with the molecular profile of neural stem/
precursor cells which has been characterized in rodents and human [36,37,38]. On these bases,
we may assume that the major cell type in our adult pig SVZ-derived neurospheres correspond
to neural multipotent progenitors, i.e. a stage of the neural lineage that is slightly more mature
than the primitive neural stem cells but equally multipotent [26]. This interpretation is
supported by additional RT-PCR data in our neurospheres: the absence of the stemness gene
transcripts CD133 and SDF-1 [39], the weakness of nucleostemin expression [40], and the lack
of detectable cyclin D2, which was demonstrated to specifically drive neural stem cells into
division onset by assaying in vivo adult neurogenesis in knockout mice for each of the three
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Figure 3. Transcriptomic profile of proliferative neurospheres from adult pig SVZ (modified from original data of refer‐
ence 26). Agarose gel electrophoretic analysis of amplicons from RT-PCR on proliferative neurosphere RNA with pri‐
mers designed on the basis of human and/or pig genomic sequences. Stem cell markers: Nestin, Hes-1, Lhx-2, p75NTR,
Sox-2, Cyclin D1, Cyclin D2. Committed progenitor markers: Pbx1, βIII-tubulin, internexin-α, NeuroD, NSE, DCX,
Mash-1, CNPase, PDGFR-α. PCR products are shown beside co-electrophoresed commercial DNA ladders.
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cyclins D [41]. Cyclin D1, which was readily expressed in the present material, conversely
operates in actively dividing neural progenitors like in most of proliferating cell types in adult
organisms.
The present data can be compared with published molecular profiling of neural progenitor
cultures from the pig foetal brain [42,43] or adult retina [44,45]. Among the 13 markers that
have been addressed by RT-PCR on mRNA extracts of proliferating neurospheres, nine yielded
similar results between foetal and adult SVZ, i.e. either negativity (CD133, SDF-1) or positivity
(nestin, Sox-2, Hes-1, Pbx-1, β-III-tubulin, doublecortin, Nogo-A). Two differences were
encountered between expanded neural cells from adult and foetal brains. The first of these was
the detectable expression of cyclin D2 in foetal, but not adult, pig neurospheres. This indicates
that neural stem cell expansion is higher in foetal than in adult neurosphere cultures [42].
Furthermore, the lack of Ki-67 detection in pre-differentiation neurospheres from foetal [42],
but not adult (present data) supports the same interpretation, since primitive neural stem cells
are much less actively dividing than neural precursors at the immediately subsequent
maturation stage [46]. Interestingly, the published molecular profile of in vitro expanded
human embryonic neural stem cells (hNSC) is very close, but not identical, to those of pig
neural precursor cells. The major difference was the expression of the stemness gene CD133
in hNSCs that otherwise expressed both Ki-67 and GFAP like adult and foetal pig cells,
respectively [42].
In the future, production of neural stem/progenitor cells from the adult pig by the present
procedure can promote cell therapy improvements, first in animal models, but also in clinical
attempts to repair neural lesions in the use of adult human. By analogy with other tissues [47,
48], adult pig neural precursor cells should be feasible for transplantation into diseased
humans without immune rejection [49,50]. The present study thus provides the substratum
for an alternative source to human allografts for transplantation in neurodegenerative
disorders or injuries, which is now open to experimentation.
3.4. In vitro lineage labelling
In order to track in vivo the fate of transplanted neural stem cells and their progenies, in vitro-
expanded neurospheres must be labeled prior to transplantation with a tag which will be
retained permanently and transmitted through division without affecting survival and
differentiation of labeled cells.
The easiest and long-established tagging method for living cell tracking after transplantation,
is incubation of dividing cells with a labeled analog of DNA biosynthesis precursors: nucleo‐
tides. Two tools are available: tritiated thymidine (3H-Thy) and bromo-deoxy-uridine (BrdU),
and can be detected in situ by autoradiography and immunohistochemistry respectively. These
tags are easy to apply and detect, but they have the major inconvenient to fade across subse‐
quent rows of cell division because of the semi-replicative mechanism of DNA replication.
Practically, this nuclear labeling becomes undetectable after 2 successive divisions of initially
labeled cells.
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Another, more recent procedure allows true lineage-labeling without fading across successive
rows of division: it consists in applying a viral vector of the green fluorescent protein (GFP)
gene, either by in vivo stereotaxic surgery into the stem cell-containing niche [51] or in vitro on
expanded primary neurospheres [52]. In collaboration with a retrovirology laboratory (U421
INSERM, Ecole Normale Supérieure, Lyon, France), we have chosen the latter approach [53]
and used a lentiviral vector of green fluorescent protein gene (LV-GFP) which had already
been validated for human dendritic cells [54]. LV-GFP was freshly synthetized, titrated and
tested as previously described [55] stored at -80°C and unfrozen just before use. Adult pig
SVZ-derived neurospheres were initially expanded through at least 2 passages. Then, 4-5 days
after the last passage, the growing neurospheres were preincubated 30 minutes in the presence
of 1mM polybrene (Sigma) and void lentiviral particles (VLP for optimal integration yield; 55)
at 0.1 x MOI (multiplicity of infection), and further incubated 2h with fresh culture medium
containing 1mM polybrene and LV-GFP at 0.3x MOI; incubation medium was then replaced
by fresh standard culture medium. LV-GFP-infected neurospheres were allowed 3 days
culture in standard conditions for optimal lineage labeling (Figure 4).
4. Improvement of post-lesional neural outcome with primary pig
neurosphere transplantation inside a venous autograft
Cell therapy for the nervous system has encountered a major empirical obstacle: in adult
mammalian brain,  the neurogenic  potential  of  neural  stem cells  is  inhibited by intrinsic
tissue microenvironment  except  for  the  very few naturally  neurogenic  areas,  which has
been formally demonstrated by heterotopic transplantation studies [56]. To overcome this
problem, we developed a novel paradigm in order to improve post-lesion regeneration in
peripheral  nerves:  transplantation  of  in  vitro-expanded,  proliferating  neurospheres  from
adult pig subventricular zone inside a homotypic venous graft which is sutured at both
ends onto the lesioned nerve ends.
Bridging a long nerve gap with a homotypic venous graft is already used in human neurology
in order to ameliorate post-lesional recovery of peripheral nerves [57,58,59,60], but it was
barely explored for neuronal cell therapy applications. The disabilities resulting from periph‐
eral nerve lesions in adults typically display no neuron loss but pathway disruption, upon
disappearance of distal axonal segments, which was extensively documented to lead to
restricted or aberrant synaptic reconnexion of surviving neurons [61]. We postulated that
neural stem cell grafting on the lesion site might overcome this limitation, by generating chains
of interconnected neurons that would functionally replace the lost nerve substance more
efficiently than existing severed neuronal axons.
To  test  this  hypothesis,  we  attempted  transplantation  of  the  proliferating  neurospheres
from adult  pig subventricular  zone (SVZ) which we had characterized above,  inside an
autologous  venous  graft,  following  surgical  transsection  of  nervis  cruralis  with  30mm-
long gap in adult pig [53]. The following section summarizes the hallmarks of this study,
methods and results [53].
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4.1. The experimental cell therapy paradigm and its functional outcome
Our lesion model was unilateral transsection of nervis cruralis with 30 mm-long gap in adult
pig, under anesthesia. This lesion induces a major motor defect, consisting in the loss of the
right leg extension over the thigh, which can be quantified by electromyography of the crural-
innervated muscle quadriceps. Our experimental cell therapy paradigm consisted in bridging
the nerve gap immediately after damage with an autologous venous segment (sampled from
vena mammalian externalis) which was sutured at the proximal end over the perinevre of the
severed nerve, filled through the opposite end of the venous graft with freshly prepared
suspension of in vitro-expanded neurospheres from adult pig SVZ (300 µL, 1000 neurospheres)
which we had previously characterized (see section II) and sutured the venous neuroguide
A
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Figure 4. Lineage labelling of neurospheres from adult pig SVZ by in vitro viral transfer of GFP gene (modelized from refer‐
ences 54, 55]. The functional structure of the lentiviral GFP vector is schematized in (A) (see 54 for more details). (B,C) Label‐
led neurospheres 3 days after in vitro infection with the lentiviral vector of GFP, as observed under a photonic microscope
with natural light (B) or green fluorescence (C). (D) In situ detection of neurosphere-derived GFP in a transplanted venous
bridge at 8 months after lesion, by fluorescent light microscopy. Legend: CMV: cytomegalovirus; gag: infection competen‐
cy coding sequence; GFP: green fluorescent protein; PPT: purine-rich element (to increase exon recognition); RRE: RNA ex‐
port responsive element; SIV: Simian immunodeficiency virus. Scale bars: 50 μm (B,C), 0.5mm (D).
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over the distal end of the severed nerve (Figure 5). Control animals did not receive neuro‐
spheres in the venous shaft before saturation. The transplanted neurospheres had been
expanded in vitro from adult pig SVZ through 2-3 passages and have been labeled in vitro with
either BrdU (for short-term post-lesional survival times) or lentivirally-transferred fluorescent
protein gene (see above, section II.4) prior to transplantation (Liard et al 2012).
B
A
Figure 5. Surgical paradigm for adult pig neural stem cell (ANSCs) transplantation inside a venous graft (modelized
from reference 53]. (A) Surgical bridging of lesioned nerve by a venous graft (below the forceps tips; the arrow points
to the distal, unsutured end of the graft). (B) Procedure schematization.
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Lesion-induced loss of leg extension on the thigh became definitive in controls (up to 8 months
after lesion) but was reversed by 90-180 days after neurosphere-filled vein grafting. Prior to
surgery, electromyograms of muscle quadriceps vast internal displayed amplitudes of 4.9 to
6.1 mV and post-stimulus latencies of 0.89 to 3.7 ms. Immediately after surgical realization of
nervis cruralis substance loss, electromyograms of muscle quadriceps were negative for all
experimental animals. Electromyography showed stimulo-detection recovery in neurosphere-
transplanted pigs which was partial at 180 days after lesion and almost complete by 240 days,
while electromyograms of controls were still negative (Liard et al 2012). Interestingly, in
neurosphere-transplanted pigs, post-stimulus latencies returned earlier to normal (i.e., at 180
days post-lesion) than electromyogram amplitude (which was fairly detectable although much
lower than on intact leg).
Therefore, transplanting in vitro purified-expanded adult neural stem cells inside a venous
neuroguide on the site of a peripheral nerve lesion promoted efficient functional recovery in
adult pig [26]. We further addressed the underlying mechanisms by post-mortem immuno‐
histochemical analysis of the bridged nerve (see below).
4.2. Exclusively neuronal fate of grafted neurosphere cells
In order to assess the fate of transplanted neurosphere cells [53], we euthanized the experimen‐
tal animals at various post-lesion intervals, sampled the experimental vein-bridged nerve
segment and processed it for immunohistochemistry (fixation by 24-hour-immersion at 4°C into
a buffered 4% paraformaldehyde solution, cryoprotection in 30% sucrose-containing phos‐
phate buffer). After snap-freezing in isopentane at -45°C, serial sagittal sections were collected
from each frozen vein-bridged nerve segment in a cryostat and processed for phenotypic marker
immunohistofluorescence. Fluorescent dyes were chosen so as to be compared with either
intrinsic green fluorescent protein (GFP) or with BrdU immunohistofluorescence, depending
on the method for neurosphere cell labeling prior to transplantation [53].
At 8 days after lesion-transplantation, BrdU-positive cells were localized inside the venous tube
as flattened spherical groups and were all immunoreactive for the specific marker of imma‐
ture migration-prone neurons: doublecortin (DCX) [53]. At longer survival delays assessed (45
to 240 days) all neurosphere-derived cells, whether labeled with BrdU or virally-transferred
GFP, expressed the specific marker of mature neurons: neuronal nuclear antigen (NeuN) or
neurofilament protein NF-68 (Figure 4; modified from ref 53). By contrast, none of labeled
neurosphere-derived cells coexpressed any of glial markers assessed: CNPase (for myelinat‐
ing glia, i.e. oligodendrocytes or Schwann cells), S-100β and GFAP (for astrocytes), at either of
post-lesional delays. Therefore adult neural stem cell-derived progenies of grafted neurospheres inside
the  venous  bridge  survived  and differentiated  into  neurons  exclusively  [53].  Moreover,  newly-
formed neurons distributed inside the venous graft along the longitudinal axis of the severed
nerve, which suggests that new neurons would have created gap-filling interconnected chains
in-between the proximal and distal ends of the severed nerve. However, such issue remains to
be investigated by using a more resolutive approach (electron microscopy).
Our finding contrasts with numerous previous attempts to improve post-lesional repair of
peripheral with putatively regenerating cell transplantation. The latter strategy, or cell therapy,
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has been attempted with primary cultures of Schwann cells [62,63], olfactory bulb enshealting
cells [64], or various types of stem cells [65]. In all these studies, progenies of grafted stem cells
mostly proved to be glial cells, which indirectly enhance axonal regeneration [65,66,67]. Since
none of these paradigms used vascular bridge for stem cell transplantation, our results suggest
that the venous wall per se stimulates neuronal differentiation of stem cell progenies. It is in
keeping with the recent demonstrations that vascular walls favor neurogenesis from adult
neural stem cells [68,69,70], which is mediated in rodent models by the vascular endothelium-
derived growth factor (VEGF) [71,72,73,74]. Our results suggest that choosing a venous trunk
versus an artificial neuroguide to bridge a nerve gap is an interesting solution because of
intrinsic property. Furthermore, all surgeons are able to take a vein trunk on superficial vein
network and this is much less expensive than neurotubes in emergency conditions.
4.3. Graft-induced activation of intrinsic Schwann cells in the lesioned nerve
At 180 and 240 days after nerve lesion and GFP-expressing neurosphere transplantation, CNPase
immunohistofluorescent labeling was much higher than in vein-bridged lesioned controls which
had not received neurosphere transplantation [53]. Both the number of CNPase-immunoreac‐
tive Schwann cell processes and their labeling intensities, as quantified by computerized image
analysis, were significantly higher in neurosphere-grafted nerves than in controls [26]. Our result
is in keeping with a previous report showing that a venous graft favored Schwann cell prolifer‐
ation after nerve lesion [75]. In our paradigm though, since controls have received a neurosphere-
devoid venous graft, our results indicated that neurosphere cells emit diffusible signals that
stimulate Schwann cells. Therefore, adult neural stem cell-derived progenies of grafted neurospheres
inside the venous bridge promoted activation of intrinsic myelinating Schwann cells. This result is in
keeping with accumulating reports demonstrating that primary neurospheres from adult brain
tissues do secrete in vitro some neurotrophic factors [76,77].
Altogether, our novel cell therapy paradigm in adult pig promotes efficient functional recovery
of a peripheral nerve after lesion with long substance loss, correlatively with genesis of new
neurons in-between the lesional gap and activation of intrinsic myelinating cells.
Similar results have been obtained in adult rat by using a similar strategy (Xu et al 2012) or
mesenchymal stem cells combined with acellular conduits (Zhao et al 2012, Jia et al 2012). From
both our and others’ studies though (as reviewed in ref 66), a pending issue remains unad‐
dressed: which is the long-term fate of ectopic graft-derived new neurons? The putative
formation of ectopic multisynaptic neuronal nets bridging the gap between the two sides of
the lesional gap, as suggested by the topographical distribution of new neurons (see above),
is made plausible by previous experimental demonstrations of synaptic connectivity between
ectopic stem cell-derived new neurons and host neural net, both in neurogenic [56] and non-
neurogenic (Lu et al 2012) adult structures of mammalian central nervous system. However,
this issue requires to be directly addressed by means of electron microscopy.
Another question arising from our results, concerns the potential long term negative effects of
grafted stem cell-derived ectopic neurons. Such transplantation might indeed result into
neuromas: either neoplastic neuromas deriving from the grafted proliferative stem cells
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(Johnson et al 2012), or non-neoplastic neuromas consisting in aberrant axonal swellings
(Rajput et al 2012).
5. Future applications of these new paradigms
The results above (sections II & III) bring about a proof-of-concept for future improvements
of neurological clinics. However, before it can be tested in human patients, our paradigm
deserves some improvements.
5.1. Alternative source of adult neural stem cells
The direct transposition of the present cell therapy strategy to human patients would raise
ethical problems, regarding either autologous sampling of patient’s subventricular zone as a
source of neurogenic neurospheres, or xenotransplantation of neurospheres from adult pig
SVZ due to currently discussed virological risks of porcine tissues [10]. A convenient alterna‐
tive can be provided by the recently discovered neurogenic stem cells of biopsied human
olfactory mucosa [84]. This tissue has been demonstrated indeed to harbor a population of
mesenchymal stem cells which displays the same neurogenic properties as original neural stem
cells after isolation and expansion in primary culture. To this aim, olfactory mucosa biopsies
are enzymatically and mechanically separated from the olfactory neuroepithelium, and the
cell suspension from the resulting tissue (olfactory chorion) is seeded in a Dulbecco’s medium
(DMEM) supplemented with F12 supplement and 10% fetal bovine serum. This primary
culture yields adherent proliferating cells that are self-renewable under passage into the same
medium. Upon seeding into serum-free DMEM supplemented with insulin, transferrin,
selenium, EGF and bFGF, olfactory chorion-derived cells grow into typical neurospheres that
exhibit the same morphology, growth kinetics and multipotentiality as neurospheres from
SVZ [3,85,86,87]. These in vitro-expanded neurogenic neurospheres were then demonstrated
to restore function and plasticity after brain lesions in adult rodents [88]. This cell preparation
would therefore represent a convenient alternative for clinical application of our cell therapy
strategy for post-lesional repair of peripheral nerves. The long-term safety of this novel cell
type should however be checked precisely in future assays, since cell therapies with mesen‐
chymal stem cells were recently documented to elicit neuromas in human patients [89].
5.2. Alternative neuroguide
Another issue in our cell therapy strategy concerns the use of autologous venous shaft as a
neuroguide. Although largely used in human clinics [57, 58], such procedure has indeed been
reported to generate inflammatory or necrotic outcomes. This risk could be avoided by using
a synthetic neuroguide which has already been shown to favor neurogenesis from transplanted
neural stem cells [59,60,90,91]. The basic neuroguide structure can be manufactured by diverse
methods: spinning mandrel technology, sheet rolling, injection-molding, freeze-drying, and
electro-spinning.
It will be interesting to study this cell enhancement with FDA- and CE-approved neuroguides
[60, 90]:
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• Nerve tubes from biodegradable and biological materials:
• type 1 collagen =Integra NeuraGen ® ; Neuro-matrix and Neurolac [91,92,93] with retro‐
spective studies [94];
• Nerve tubes from biodegradable and synthetic materials :
• polyglycolic acid PGA = NEUROTUBE® [95,96] ;
• poly-lactic-glycolic acid (PLGA) ;
• poly-L-lactide-caprolactone (PLCL) Neurolac® [97];
• polyvinyl alcohol hydrogel SaluBridge.
• Nerve guide with internal multitubular architecture, which is required for bridging long
nerve gaps. If we take this point of view, acellular nerve graft Axogen’Avance ® is prom‐
issing and obtained by cryocongelation and chimical treatment from human nerves [93,98].
The graft can be handled like an autograft, held by epineurium and bridge gaps up to 50
mm.
With synthetic neurotube, three-dimensional scaffold can be obtained by electrospinning and
progress with nanotechnologies. This approach could be optimized with extracellular matrix
(ECM) proteins or peptides (laminin-1) and neurotrophic growth factors like basic fibroblast
growth factor (bFGF), brain derived neurotrophic factor (BDNF) or nerve growth factor (NGF)
[99].
Above all maybe, the use of acellular or totally synthetic conduits for nerve gap bridging is a
priori likely to reduce the risk of post-operative neuromas. More systematic and extensive
studies are required to evaluate properly the risk over benefit probability ratios of all available
combinations. For instance, a novel cell therapy strategy which differs from ours merely by
using an acellular vein graft, was recently reported to produce only 35-75% of neural cells,
including glial and proliferative cells along with neurons [100]. The highly positive pro-repair
impact of autologous vein wall, which we have empirically demonstrated, may prove difficult
to mimic with man-controlled substitutes.
6. Conclusion
Thus, transplantation of neural stem cells from adult mammalian brain inside an autologous
venous graft provides an efficient repair strategy, in the pig model. Our study provides the
proof-of-concept for further study in human clinics. It also provides progress in basic cell
biology, since the grafted exogenous neurospheres were shown to promote nerve regeneration
through 2 distinct original mechanisms: i) indirect activation of intrinsic myelinating glial cells
(as recently reviewed in 66), and ii) genesis of new neurons aligned in-between the two ends
of the severed nerve. The latter one is totally novel in the field of post-lesional plasticity and
repair of peripheral nerves. It deserves though further analysis, by deciphering the neuro‐
transmitter phenotype of neurosphere-derived new neurons and their ultrastructural pattern
of connectivity.
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